Vertex
Stories
-
Genomics announces extension of strategic drug discovery collaboration with Vertex
Genomics announced a four-year extension of its eight-year drug target discovery and validation collaboration with Vertex, beginning November 18, 2026. The total potential contract value exceeds $220 million for milestone achievements and future royalties.